DAM
PVLA

Deltec Asset Management’s Palvella Therapeutics PVLA Stock Holding History

Deltec Asset Management’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$367K Hold
2,400
– – 0.05% 195
2026
Q1 		$299K Hold
2,400
– – 0.05% 181
2025
Q4 		$251K Sell
2,400
-10,100
-81% -$862K 0.04% 184
2025
Q3 		$784K Hold
12,500
– – 0.13% 108
2025
Q2 		$282K Hold
12,500
– – 0.05% 159
2025
Q1 		$350K Hold
12,500
– – 0.08% 135
2024
Q4 		$150K Buy
+12,500
New +$196K 0.03% 152

Other funds holding PVLA

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
CAM
Clio Asset Management Charlottesville, Virginia $126M AUM 16.01% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return

Deltec Asset Management's PVLA Position: Q2 2026 in Review

Deltec Asset Management held its Palvella Therapeutics (PVLA) position steady in Q2 2026 at 2,400 shares worth $367K. The position accounts for 0.05% of the portfolio, ranked #195.

Deltec Asset Management first reported a position in PVLA in Q4 2024 and has held it in 7 quarters since. The position peaked at $784K in Q3 2025. 32 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • Deltec Asset Management held 2,400 shares of Palvella Therapeutics worth $367K as of Q2 2026.
  • Deltec Asset Management left its Palvella Therapeutics share count unchanged in Q2 2026.
  • Palvella Therapeutics made up 0.05% of Deltec Asset Management's portfolio in Q2 2026, its #195 holding.
  • Deltec Asset Management first reported a position in Palvella Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Deltec Asset Management's Palvella Therapeutics position peaked at $784K in Q3 2025.
  • 32 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Deltec Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.